Tango Therapeutics (TNGX) Consolidated Net Income: 2020-2025
Historic Consolidated Net Income for Tango Therapeutics (TNGX) over the last 6 years, with Sep 2025 value amounting to $15.9 million.
- Tango Therapeutics' Consolidated Net Income rose 154.46% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.5 million, marking a year-over-year increase of 18.57%. This contributed to the annual value of -$130.3 million for FY2024, which is 28.07% down from last year.
- According to the latest figures from Q3 2025, Tango Therapeutics' Consolidated Net Income is $15.9 million, which was up 140.88% from -$38.9 million recorded in Q2 2025.
- In the past 5 years, Tango Therapeutics' Consolidated Net Income ranged from a high of $15.9 million in Q3 2025 and a low of -$39.9 million during Q1 2025.
- In the last 3 years, Tango Therapeutics' Consolidated Net Income had a median value of -$29.2 million in 2024 and averaged -$26.8 million.
- Per our database at Business Quant, Tango Therapeutics' Consolidated Net Income slumped by 951,806.78% in 2021 and then surged by 154.46% in 2025.
- Over the past 5 years, Tango Therapeutics' Consolidated Net Income (Quarterly) stood at -$22.1 million in 2021, then crashed by 31.98% to -$29.1 million in 2022, then dropped by 5.65% to -$30.8 million in 2023, then fell by 22.37% to -$37.6 million in 2024, then spiked by 154.46% to $15.9 million in 2025.
- Its last three reported values are $15.9 million in Q3 2025, -$38.9 million for Q2 2025, and -$39.9 million during Q1 2025.